FORA Capital’s NeoGenomics NEO Stock Holding History

FORA Capital’s Portfolio NEO Stock Details NEO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,471	Closed	-$83.9K	–	618
2025 Q2	$83.9K	Buy	+11,471	New	+$92.6K	0.01%	471
2022 Q2	–	Sell	-25,237	Closed	-$327K	–	598
2022 Q1	$327K	Buy	+25,237	New	+$531K	0.06%	368
2021 Q1	–	Sell	-2,421	Closed	-$130K	–	983
2020 Q4	$130K	Buy	+2,421	New	+$109K	0.02%	607
2020 Q2	–	Sell	-6,889	Closed	-$190K	–	1164
2020 Q1	$190K	Buy	+6,889	New	+$206K	0.04%	465

Other funds holding NEO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

Greenhouse Funds Baltimore, Maryland $1.96B AUM 36.47% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

FORA Capital's NEO Position: Q3 2025 in Review

FORA Capital sold out of NeoGenomics (NEO) in Q3 2025, closing a stake of 11,471 shares — an estimated $83.9K sold.

FORA Capital first reported a position in NEO in Q1 2020 and held it in 4 quarters. The position peaked at $327K in Q1 2022. 254 funds tracked by Wall St. Rank hold NEO as of Q3 2025.

FORA Capital reported no remaining NeoGenomics position as of Q3 2025 after selling out during the quarter.
FORA Capital sold 11,471 NeoGenomics shares in Q3 2025, an estimated $83.9K.
FORA Capital first reported a position in NeoGenomics in Q1 2020 and held it in 4 quarters.
FORA Capital's NeoGenomics position peaked at $327K in Q1 2022.
254 funds tracked by Wall St. Rank held NeoGenomics as of Q3 2025.

Based on FORA Capital's 13F filing for Q3 2025, filed 13 Nov 2025.